[
  {
    "_type": "metadata",
    "video_title": "J&J Lowers Drug Prices",
    "tags": [
      "Johnson & Johnson",
      "US Government",
      "Drug Prices",
      "Healthcare",
      "Pharmaceuticals",
      "Medicine",
      "Prescription Costs",
      "Healthcare Reform",
      "Medical Expenses"
    ],
    "topic": "johnson & johnson strikes deal with u.s. government to lower drug prices",
    "date": "January 10, 2026"
  },
  {
    "keyword": "prescription drugs",
    "identity_keyword": "Johnson & Johnson",
    "text": "A major pharmaceutical company has made a significant deal with the US government to lower medication prices.",
    "duration": 3,
    "visual_type": "identity"
  },
  {
    "keyword": "medication bottles",
    "identity_keyword": "",
    "text": "The agreement will affect several popular prescription drugs used to treat various health conditions.",
    "duration": 3,
    "visual_type": "emotion"
  },
  {
    "keyword": "healthcare professionals",
    "identity_keyword": "",
    "text": "The goal of the deal is to increase access to affordable healthcare for millions of people.",
    "duration": 4,
    "visual_type": "emotion"
  },
  {
    "keyword": "government building",
    "identity_keyword": "US Department of Health and Human Services",
    "text": "The deal is the result of months of negotiations between the company and the US government.",
    "duration": 4,
    "visual_type": "identity"
  },
  {
    "keyword": "insurance cards",
    "identity_keyword": "",
    "text": "The price reductions will apply to patients with different types of insurance.",
    "duration": 4,
    "visual_type": "emotion"
  },
  {
    "keyword": "financial documents",
    "identity_keyword": "",
    "text": "The exact details of the pricing structure have not been fully disclosed.",
    "duration": 4,
    "visual_type": "emotion"
  },
  {
    "keyword": "patient advocacy groups",
    "identity_keyword": "",
    "text": "Patient advocacy groups and healthcare professionals have welcomed the news.",
    "duration": 4,
    "visual_type": "emotion"
  },
  {
    "keyword": "question marks",
    "identity_keyword": "",
    "text": "Many questions still remain about the long-term implications of the deal.",
    "duration": 4,
    "visual_type": "emotion"
  },
  {
    "keyword": "financial charts",
    "identity_keyword": "",
    "text": "The deal may affect the company's bottom line in the long run.",
    "duration": 4,
    "visual_type": "emotion"
  },
  {
    "keyword": "pharmaceutical companies",
    "identity_keyword": "",
    "text": "Other pharmaceutical companies may follow suit in the future.",
    "duration": 4,
    "visual_type": "emotion"
  },
  {
    "keyword": "calendar pages",
    "identity_keyword": "",
    "text": "The true impact of the agreement may not be fully understood for several years.",
    "duration": 3,
    "visual_type": "emotion"
  },
  {
    "keyword": "analysts working",
    "identity_keyword": "",
    "text": "Analysts are still trying to understand the implications of the deal.",
    "duration": 3,
    "visual_type": "emotion"
  },
  {
    "keyword": "healthcare industry",
    "identity_keyword": "",
    "text": "The deal has sent shockwaves through the healthcare industry.",
    "duration": 3,
    "visual_type": "emotion"
  },
  {
    "keyword": "prescription pills",
    "identity_keyword": "",
    "text": "The future of drug pricing is uncertain.",
    "duration": 3,
    "visual_type": "emotion"
  }
]